From the phase 3 trials at the 9 mg and 12 mg doses: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% with placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% with placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% with placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) Compare those numbers to Mounjaro and the difference is clear
The reasons may be threefold: first, hyperglycemia leads to heme degradation in hemoglobin and myoglobin, resulting in the detachment of iron ions from heme
Side effects observed in the Lcarnitine group included nausea (3 patients), anorexia (2 patients), abdominal pain (2 patients), vomiting (1 patient), and dizziness (1 patient)
Book a consultation at our Lincoln Park clinic or via telehealth anywhere in Illinois
At 8mg and 12mg, proactive management is essential
Training For Hypertrophy: Charles Poliquin Seminar Selected Notes (Pt 1) Please note that my own brief explanations / contextualisations are in italics and are my own views